Hormone-sensitive lipase-independent adipocyte lipolysis during beta-adrenergic stimulation, fasting, and dietary fat loading

Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E282-8. doi: 10.1152/ajpendo.00203.2003.

Abstract

In white adipose tissue, lipolysis can occur by hormone-sensitive lipase (HSL)-dependent or HSL-independent pathways. To study HSL-independent lipolysis, we placed HSL-deficient mice in conditions of increased fatty acid flux: beta-adrenergic stimulation, fasting, and dietary fat loading. Intraperitoneal administration of the beta(3)-adrenergic agonist CL-316243 caused a greater increase in nonesterified fatty acid level in controls (0.33 +/- 0.05 mmol/l) than in HSL(-/-) mice (0.12 +/- 0.01 mmol/l, P < 0.01). Similarly, in isolated adipocytes, lipolytic response to CL-316243 was greatly reduced in HSL(-/-) mice compared with controls. Fasting for <or=48 h produced normal mobilization and oxidation of fatty acids in HSL(-/-) mice, as judged by similar values of respiratory quotient and oxygen consumption as in HSL(+/+) controls. In isolated adipocytes, lipolysis in the absence of beta-adrenergic stimulation was 1.9-fold greater in HSL(-/-) than in HSL(+/+) cells (P < 0.05), increasing to 6.5-fold after fasting (P < 0.01). After 6 wk of a fat-rich diet containing 31.5% of energy as lipid, weight gain of HSL(-/-) mice was 4.4-fold less than in HSL(+/+) mice (P < 0.01), and total abdominal fat mass was 5.2-fold lower in HSL(-/-) than in HSL(+/+) mice (P < 0.01). In white adipose tissue, HSL is essential for normal acute beta-adrenergic-stimulated lipolysis and permits normal triglyceride storage capacity in response to dietary fat loading. However, HSL-independent lipolysis can markedly increase during fasting, both in isolated adipocytes and in intact mice, and can mediate a normal flux of fatty acids during fasting.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Adrenergic beta-Agonists / pharmacology*
  • Analysis of Variance
  • Animals
  • Cells, Cultured
  • Dietary Fats / metabolism
  • Dietary Fats / pharmacology
  • Dioxoles / pharmacology
  • Energy Metabolism / drug effects
  • Energy Metabolism / genetics
  • Fasting / metabolism*
  • Fatty Acids / metabolism*
  • Fatty Acids / pharmacology
  • Female
  • Homeostasis / drug effects
  • Homeostasis / genetics
  • Lipolysis / drug effects
  • Lipolysis / physiology*
  • Male
  • Mice
  • Mice, Knockout
  • Motor Activity / drug effects
  • Motor Activity / genetics
  • Sterol Esterase / deficiency
  • Sterol Esterase / genetics
  • Sterol Esterase / physiology*

Substances

  • Adrenergic beta-Agonists
  • Dietary Fats
  • Dioxoles
  • Fatty Acids
  • disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate
  • Sterol Esterase